Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5 | N/A | -2,553 | -982 | -3 |
| Depreciation Amortization | 0 | N/A | 776 | 284 | 0 |
| Accounts receivable | 205 | N/A | -198 | -197 | N/A |
| Accounts payable and accrued liabilities | 4 | N/A | N/A | N/A | 3 |
| Other Working Capital | 4 | N/A | 200 | -25 | 3 |
| Other Operating Activity | -209 | 0 | 1,007 | 595 | -3 |
| Operating Cash Flow | $-2 | $N/A | $-769 | $-325 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | N/A | -6 | -6 | N/A |
| Investing Cash Flow | $-58 | $N/A | $-6 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 800 | N/A | 800 | N/A | N/A |
| Debt Issued | 270 | N/A | 270 | 265 | 0 |
| Debt Repayment | -233 | N/A | -52 | -38 | N/A |
| Common Stock Issued | 6 | N/A | N/A | N/A | 3 |
| Other Financing Activity | -837 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $6 | $N/A | $1,018 | $227 | $3 |
| Beginning Cash Position | 2 | N/A | 201 | 201 | 1 |
| End Cash Position | 6 | N/A | 445 | 98 | 4 |
| Net Cash Flow | $4 | $N/A | $244 | $-104 | $3 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2 | N/A | -769 | -325 | 0 |
| Capital Expenditure | -58 | N/A | -6 | -6 | N/A |
| Free Cash Flow | -60 | 0 | -774 | -331 | 0 |